Showing 2341 - 2350 of 3137 for "Pharmaceuticals and life sciences" with applied filters
12 April 2023 by
In line with its continuing growth, DSK Legal has shifted to larger offices in Mumbai and Pune. Equipped with the necessary amenities and state-of-the-art infrastructure, the new offices will provide a harmonious work environment for lawyers and clients.
04 April 2023 by
This guide, which focuses on how foreign corporations can set up a legal presence in the Philippines, was first published in 2015, when our firm celebrated its 70th anniversary, and this most recent update was prepared in connection with our 78th anniversary celebrations.
03 April 2023 by
DSK Legal has promoted Associate Partners Abhishek Singh Baghel, Jayesh Kothari, Mitali Naik and Nakul Batra as Partners; and Principal Associates Akanksha Tiwary, Prachi Garg and Prachi Gupta as Associate Partners.
30 March 2023 by
SyCipLaw's Banking, Finance & Securities Department's Banking Bulletin for March 2023 features the latest issuances from the Bangko Sentral ng Pilipinas (BSP) and the NAtional Provacy Commission (NPC).
28 March 2023 by
A visually appealing store is a crucial asset for any business aiming to provide a consistent quality of goods and services across its stores . These stores featuring a distinct theme design commonly seen on their signage, wall arts, overall décor etc. not only reflects a cohesive brand imagery of the business but also create a lasting impression on the customers, strengthening their brand recall value.
27 March 2023 by
Our dedicated series on the P2SK Law continues with our latest Advisory, which explores the changes brought by Chapter V, amending the Capital Market, Money Market, and Forex Market. Following the enactment of the P2SK Law, we can expect many new implementing regulations in the financial sector. Participants in the financial markets should anticipate compliance changes and prepare to quickly adapt to any necessary adjustments.
27 March 2023 by
The Government of Indonesia moves forward the development of Indonesia’s new capital city, namely Ibu Kota Nusantara (“IKN”) by issuing several underlying regulations to date in effort to encourage the participation of private sector in accelerating the infrastructure development of the IKN. One of them being the groundworks to implement the public-private partnerships in such development. With a total cost estimate of more than IDR460 trillion (or approximately USD30 billion), the five-stages development of IKN is targeted to be 80% funded from non-State Budget and therefore can be expected to attract private investors participation in it. This advisory provides an overview of the funding schemes and private sector participation in the development of IKN.
24 March 2023 by
DeHeng Law Offices (“DeHeng”), one of the largest Chinese law firms with a global presence, recently announced the successful completion of its merger with a local law firm in Hong Kong, as part of its efforts to enhance its service offerings in the Asian financial hub.
24 March 2023 by
Following our previous Advisory on Indonesia’s long-awaited Law No. 27 of 2022 on Personal Data Protection (the “PDP Law”) (view the Advisory here), this Advisory focuses on the transfer of personal data from Indonesia to other countries (cross-border transfers). The PDP Law is binding on all parties that process or control personal data in or outside Indonesia with a legal impact in Indonesia or on Indonesian data subjects. Companies must comply with the PDP Law to protect the rights of data subjects during cross-border data transfers. Full compliance is required by October 17, 2024, with a two-year transitional period as of the law's enactment.
23 March 2023 by
It is generally known and understood that every exception in the act should stand on its own footing. Two seemingly similar provisions in legal sense cannot lean back on one another to fortify the argument favouring the exception or otherwise. This seemingly sound argument suffers the close scrutiny of the Delhi High court in Best Agrolife Limited v Deputy Controller of Patents & Anr (WP(C)-IPD 11/2022 & CM 32/2022, 54/2022, 55/2022).
